Amnioinfusion for Postpartum Hemorrhage
(PURPOSE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion of any blood products or iii) hysterectomy
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is amnioinfusion generally safe for humans?
How does the treatment Prophylactic Amnioinfusion for Postpartum Hemorrhage differ from other treatments?
Prophylactic Amnioinfusion is unique because it involves introducing fluid into the uterus during labor to manage complications like meconium (a newborn's first stool) and low amniotic fluid levels, which can help reduce fetal distress and improve outcomes. This method is considered safe and effective, with fewer adverse effects compared to other treatments.13678
What data supports the effectiveness of the treatment Prophylactic Amnioinfusion for Postpartum Hemorrhage?
Research on prophylactic amnioinfusion in women with low amniotic fluid during labor shows it can reduce the need for cesarean sections and other interventions, suggesting it helps improve outcomes during childbirth. This indicates that amnioinfusion may be beneficial in managing complications, although its direct effectiveness for postpartum hemorrhage is not specifically studied.6791011
Who Is on the Research Team?
Sarah Mehl, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for individuals at risk of postpartum hemorrhage (PPH) after giving birth. Specific eligibility criteria are not provided, but typically participants would be pregnant women nearing delivery who meet the study's health requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive prophylactic amnioinfusion to prevent postpartum hemorrhage
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on postpartum hemorrhage outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Prophylactic Amnioinfusion
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor